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Abstract
Background:  Phorbol 12-myristate 13-acetate (PMA) is often used as an activating phorbol ester
of protein kinase C (PKC) to investigate the roles of the kinase in cellular functions. Accumulating
lines of evidence indicate that in addition to activating PKC, PMA also produces some regulatory
effects in a PKC-independent manner. In this study, we investigated the non-PKC effects of PMA
on electrical excitability of rat pancreatic β -cells by using patch-clamp techniques.
Results:  In current-clamp recording, PMA (80 nM) reversibly inhibited 15 mM glucose-induced
action potential spikes superimposed on a slow membrane depolarization and this inhibition can
not be prevented by pre-treatment of the cell with a specific PKC inhibitor, bisindolylmaleimide
(BIM, 1 µM). In the presence of a subthreshold concentration (5.5 mM) of glucose, PMA
hyperpolarized β -cells in a concentration-dependent manner (0.8–240 nM), even in the presence
of BIM. Based on cell-attached single channel recordings, PMA increased ATP-sensitive K+ channel
(KATP) activity. Based on inside-out patch-clamp recordings, PMA had little effect on KATP activity
if no ATP was in the bath, while PMA restored KATP activity that was suppressed by 10 µM ATP
in the bath. In voltage-clamp recording, PMA enhanced tolbutamide-sensitive membrane currents
elicited by repetitive ramp pulses from -90 to -50 mV in a concentration-dependent manner, and
this potentiation could not be prevented by pre-treatment of cell with BIM. 4α -phorbol 12,13-
didecanoate (4α -PDD), a non-PKC-activating phorbol ester, mimicked the effect of PMA on both
current-clamp and voltage-clamp recording configurations. With either 5.5 or 16.6 mM glucose in
the extracellular solution, PMA (80 nM) increased insulin secretion from rat islets. However, in
islets pretreated with BIM (1 µM), PMA did not increase, but rather reduced insulin secretion.
Conclusion:   In rat pancreatic β -cells, PMA modulates insulin secretion through a mixed
mechanism: increases insulin secretion by activation of PKC, and meanwhile decrease insulin
secretion by impairing β -cell excitability in a PKC-independent manner. The enhancement of KATP
activity by reducing sensitivity of KATP to ATP seems to underlie the PMA-induced impairment of
β -cells electrical excitation in response to glucose stimulation.
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Background
Phorbol esters are often used as activators of protein ki-
nase C (PKC) to investigate the role of the kinase in cel-
lular functions [1]. Pancreatic β -cells possess α , β 1, δ  and
ε  PKC isotypes [2], and activation of PKC is known to
synergize with glucose stimulation in insulin secretion
[3–5]. PKC, via protein phosphorylation seems to facili-
tate exocytosis of insulin granules [6–8]. In glucose-
stimulated insulin secretion, ATP-sensitive K+ channels
(KATP (SUR1, Kir6.2)) play a crucial role [9,10]. ATP pro-
duced by the metabolism of glucose inhibits KATP activi-
ty, resulting in development of depolarization
responsible for opening of L-type Ca2+ channels, allow-
ing Ca2+ influx. Elevation of intracellular Ca2+ ([Ca2+]i)
accelerates exocytosis of insulin granules. The possibility
that KATP activity is regulated by PKC has long been
studied. In this respect, however, contradictory results
have been obtained. For example, in insulin-secreting
cell lines, PKC was reported to potentiate KATP activity
[11,12], although PKC-dependent inhibition [13] or inhi-
bition followed by activation [14] has been also reported.
In primary β -cells from the mouse, activation of PKC by
PMA did not cause any change in membrane potential
[15,16], although in the same cell type, PMA reduced the
glucose-stimulated elevation of [Ca2+]i depending on ac-
tivation of PKC [16]. On the other hand, recent studies in
myocytes suggest that activation of PKC increases the
open-time probability of KATP (SUR2, Kir6.1) by reduc-
ing the sensitivity of KATP to ATP [17–20]. Therefore,
whether regulation of insulin secretion by PMA is medi-
ated through PKC or not is still obscure. Recently, we re-
ported that phorbol ester inhibited Ca2+ influx through
PKC-dependent and PKC-independent pathways [21]. In
the present study, we further evaluated the non-PKC
mechanism of PMA action on β -cell electrical excitation
by using patch-clamp techniques. The results indicate
that in rat pancreatic β -cells, PMA modulates insulin se-
cretion through a mixed mechanism: increases insulin
secretion by activation of PKC, and meanwhile decrease
insulin secretion by impairing β -cell excitability in a
PKC-independent manner. The enhancement of KATP
activity by reducing sensitivity of KATP to ATP seems to
underlie the PMA-induced impairment of β -cells electri-
cal excitation in response to glucose stimulation.
Results
PMA inhibits electrical excitation of single rat β -cells
With glucose at 5.5 mM in the extracellular solution, the
membrane potential, measured using the nystatin-perfo-
ration technique, was stable (-52.9 ± 1.1 mV, mean ± SE,
n = 28). Bath-applied 15 mM glucose induced the action
potential spikes superimposed on a slow membrane de-
polarization (Fig. 1 panel A). When PMA (80 nM) was
applied to the cell during 15 mM glucose stimulation,
both slow depolarization and action potentials was abol-
ished. The effect of PMA was reversible after removal of
PMA (Fig. 1 panel A). This inhibitory effect by PMA ap-
peared to be independent of PKC since addition of the
PKC blocker, BIM (1 µM) did not prevent PMA-induced
inhibition (Fig. 1 panel B). In two experiments, higher
concentration (10 µM) of BIM failed to prevent PMA-in-
duced inhibition too (data not shown). In the presence of
5.5 mM glucose, 63% of tested β -cells (5/8) showed
spontaneous action potentials superimposed on a slow
depolarizing potential, and PMA (80 nM) inhibited these
action potentials as well (Fig. 1 panel C).
PMA induces hyperpolarization of rat β -cells
In the presence of 5.5 mM glucose, application of PMA
(80 nM) alone induced a slow, reversible membrane hy-
perpolarization (Fig. 2 panel A). The magnitude of the
hyperpolarization depended on the concentration of
PMA (Fig. 2 panel C). Pretreatment of cells with the PKC
inhibitor, BIM (1 µM) for about 60 min did not prevent
PMA-induced hyperpolarization (Fig. 2 panel B). Figure
2C summarized that PMA-induced hyperpolarization
was not significantly different between BIM-treated and
BIM-untreated β -cells (Fig. 2 panel C). These results in-
dicate that PMA-induced hyperpolarization of pancreat-
ic β -cells is not mediated through PKC activation.
PMA increases KATP activity in cell-attached single channel 
recording
Since KATP plays a crucial role in glucose-stimulated in-
sulin secretion, PMA-induced hyperpolarization could
be mediated by changes in KATP activity. To test this hy-
pothesis, we examined the effect of PMA on single chan-
nel activities of KATP. In the cell-attached configuration,
spontaneous single channel currents were recorded at a
pipette potential of 0 mV (Fig. 3). The specific KATP
blocker, tolbutamide (0.5 mM) completely inhibited
channel activity (Fig. 3), indicating that the recorded sin-
gle channel currents are passed through KATP channels.
Application of 80 nM PMA to the bath solution signifi-
cantly increased channel activities (Fig. 3). Values of
open-time probability for KATP were 0.08 ± 0.01 before
application of PMA and 0.11 ± 0.01 during application of
PMA (n = 9, Mean ± SEM, P < 0.01). This result indicates
that PMA indeed increases KATP activity.
PMA increases whole-cell membrane current through KATP
In the whole-cell configuration, membrane currents in
response to repeatedly applied voltage ramp pulses from
-90 to -50 mV were recorded. Tolbutamide (0.5 mM)
markedly reduced the size of the current, and after block-
ade of membrane current, PMA failed to increase the
current (Fig. 4 panel A), suggesting that PMA increased
membrane currents through KATP. Application of PMA
(80 nM) increased the magnitude of membrane current
(Fig. 4 panel B) and the magnitude of increased currentsBMC Pharmacology 2001, 1:3 http://www.biomedcentral.com/1471-2210/1/3
Figure 1
Effect of PMA on electrical excitation of single rat pancreatic β -cells. The membrane potential was measured the nystatin-per-
foration method. (A) Increases in extracellular glucose concentration from 5.5 to 15 mM induced a slow membrane depolariza-
tion superimposed on action potentials. Addition of PMA (80 nM) inhibited action potentials also membrane depolarization. (B)
In the cell treated with BIM (1 µM, for one hour), PMA (80 nM) still inhibited extracellular glucose-induced membrane depo-
larization and action potentials. (C) In the presence of 5.5 mM glucose, some cells (5/8) showed spontaneous electrical excita-
tion, which also inhibited by PMA. The concentration of glucose in the extracellular solution was 5.5 mM. Dotted lines indicate
the membrane potential level before stimulation with glucose or PMA. Representative tracings from at least six experiments
are shown.BMC Pharmacology 2001, 1:3 http://www.biomedcentral.com/1471-2210/1/3
Figure 2
PMA induced membrane hyperpolarization. (A) PMA (80 nM) applied during a steady-state phase of membrane potential in a
solution containing 5.5 mM glucose caused a slow hyperpolarization. (B) In cells treated with BIM (1 µM), PMA (80 nM)
induced a similar slow hyperpolarization. Representative traces in A and B from at least six experiments are shown. (C) Con-
centration-response relationships of PMA-induced hyperpolarization in cells treated and untreated with BIM. Results are from
5–8 experiments. The vertical bars represent SEM. The values with PMA at the same concentration are not significantly differ-
ent in cells treated or untreated with BIM.BMC Pharmacology 2001, 1:3 http://www.biomedcentral.com/1471-2210/1/3
depended on the concentrations of PMA (Fig. 4 panel D).
In cells treated with BIM (1 µM), PMA still increased
membrane current (Fig. 4 panel C). No significant differ-
ences were observed between BIM-untreated and treat-
ed cells for PMA-induced membrane current increase
(Fig. 4 panel D), suggesting that PMA increases KATP-
mediated currents in a PKC-independent manner.
4α -PDD mimics the effect of PMA on electrical properties 
of rat β -cells
There are two ways to test the hypothesis that the effect
of PMA on electrical properties of rat β -cells is independ-
ent of PKC activation. One is to use specific PKC block-
ers, like BIM, to examine whether the effect of PMA can
be prevented (Fig. 1,2,4). Another way is to employ PMA
analogs, which do not stimulate PKC, to see if they can
mimic the PMA effect. 4α -PDD, as a PKC non-stimulat-
ing phorbol ester [22], provides a good opportunity to
test our hypothesis. As shown in Fig. 5 panel A, 4α -PDD
(1 µM) completely abolished action potentials elicited by
elevation of glucose concentration from 5.5 to 15 mM,
just like the PMA effect in Fig. 1 panel A. In voltage-
clamp current recordings (Fig. 5 panel B), 4α -PDD (1
µM) increased membrane current evoked by ramp from
-90 to -50 mV, similar to the PMA effect in figure 4 panel
B. The similar results have also been obtained by low
concentration of 4α -PDD (80 nM, n = 3 for current-
clamp data and n = 2 for voltage-clamp data, data not
shown). These results indicate that 4α -PDD virtually
mimics PMA effects, and these data further support the
idea that the increase of KATP activity by PMA does not
depend on PKC activation.
Possible mechanism of PMA increases KATP activity
How does PMA increase KATP activity? Two possible ex-
planations might be addressed. First, PMA reduces the
sensitivity of KATP to ATP as reports using myocytes [17–
20]. Second, PMA may reduce ATP production. To assess
the effects of PMA on KATP activity, we performed two
experiments. First, using inside-out recording configura-
tion, spontaneous single channel activities were more
prominent when there was no ATP in bath solution (in-
tracellular face), and recorded currents were very sensi-
tive to bath-applied tolbutamide (0.5 mM, Fig. 6 panel
A). In the absence of ATP in the bath, application of PMA
showed little effect on KATP activity (Fig. 6 panel B). Val-
ues of the open-time probability for KATP were 0.19 ±
0.02 (n = 12) without and 0.20 ± 0.02 (n = 5) with 80 nM
PMA (P > 0.05). The average single channel conductanc-
es were 68 pS without and 66 pS with 80 nM PMA, meas-
ured between -90 to 0 mV (Fig. 6 panel D). Application
of 10 µM ATP to the bath decreased the open probability
of KATP, and under this condition, PMA restored KATP
activity (Fig. 6 panel C) even in the presence of 1 µM BIM
(Fig. 6 panel E). Values for ATP concentration producing
half-maximal inhibition of KATP, taken from the concen-
tration-response relationships of ATP inhibition of KATP
activity, were 10.8 ± 1.9 µM (n = 6) without and 24.9 ± 4.9
µM (n = 5) with 80 nM PMA (P <0.05, Fig. 6 panel F).
Values of the Hill coefficient were 1.04 ± 0.02 without
and 1.08 ± 0.02 with PMA (P > 0.05). These results indi-
cate that PMA increases KATP activity in the presence of
intracellular ATP, which implies that PMA may reduce
the sensitivity of KATP to ATP. Second, the ATP content
of rat islets was measured during PMA treatment. As
shown in Table 1,10 min loading of islets with extracellu-
lar solution containing 80 nM PMA did not alter ATP
Figure 3
PMA induces KATP activity recorded in the cell-attached configuration. Single channel recordings in the cell-attached configura-
tion are shown. The pipette potential (Vp) was held at 0 mV. Application of 80 nM PMA to the bath increased channel opening.
Tolbutamide (0.5 mM), applied to the bath during PMA, completely inhibited channel activity, suggesting that PMA increased
KATP activity.BMC Pharmacology 2001, 1:3 http://www.biomedcentral.com/1471-2210/1/3
Figure 4
The effect of PMA on membrane current in response to voltage ramp pulses. Whole cell membrane currents in response to
voltage ramps from -90 to -50 mV, recorded while clamping the ATP concentration at 1 mM in the pipette solution, are shown.
(A) The effect of tolbutamide (0.5 mM), and the effect of PMA (80 nM), applied on top of tolbutamide exposure. (B) The effect
of PMA (80 nM) alone. (C) The effect of PMA on cells treated with BIM (1 µM). (D) Concentration-response relationships for
the PMA effect on currents in cells treated or untreated with BIM (1 µM). The size of membrane current was expressed rela-
tive to that before application of PMA. The values with PMA at the same concentration are not significantly different for cells
treated with or without BIM. Results are from 5–7 experiments.BMC Pharmacology 2001, 1:3 http://www.biomedcentral.com/1471-2210/1/3
content of islets. On the other hand, loading cells with 1
mM NaCN markedly reduced ATP content.
Effects of PMA on glucose-induced insulin secretion
The results presented such far indicate that PMA de-
creases electrical excitation of β -cells and this effect is in-
dependent on PKC activation. According to insulin
secretion theory, decrease of electrical excitation of β -
cells should reduce insulin secretion. To address this
question, we measured insulin secretion from rat islets.
As shown in Fig. 7, PMA (80 nM) increase both basal (5.5
mM glucose in the extracellular solution) and evoked
(16.6 mM glucose in the extracellular solution) insulin
secretion rates. However, as we expected, in BIM-treated
islets PMA (80 nM) decreased the rates of insulin secre-
tion (Fig. 7). These data indicate that PMA regulates in-
sulin secretion mediated by a mixed mechanism, a PKC-
dependent increase of insulin secretion and a PKC-inde-
pendent decrease of insulin secretion.
Discussion
Phorbol esters are often used as activators of PKC to in-
vestigate the role of the kinase in cellular functions [1].
Accumulating lines of evidence indicates that PMA plays
a complex role in regulation of cellular function, includ-
ing PKC-dependent [18–20] and PKC-independent ways
[23,24,21]. In the present results, PMA inhibited slow
membrane depolarization and action potentials in re-
sponse to glucose stimulation (Fig. 1), and caused a
membrane hyperpolarization in rat β -cells (Fig. 2).
These findings are consistent with the observation that
12-O-tetradecanoylphorbol 13-acetate lowers [Ca2+]i at a
stimulatory glucose concentration in pancreatic islets
from obese-hyperglycaemic mice [16]. Since PMA in-
Figure 5
The effect of 4α -PDD (1 µM) on β -cell electrical excitation. (A) Effect of 4α -PDD on glucose (15 mM)-induced depolarization
and action potential. (B) effect of 4α -PDD on ramp pulse-induced membrane current. Dotted lines indicate the control level of
membrane current. Representative tracings from at least six experiments are shown.BMC Pharmacology 2001, 1:3 http://www.biomedcentral.com/1471-2210/1/3
Figure 6
Effect of PMA on the ATP inhibition of KATP activity. (A) Single channel current recordings in the inside-out configuration. The
transmembrane potential was -60 mV (inside negative). Tolbutamide was applied to the intracellular side of the membrane at
0.5 mM. Inhibition of the current by tolbutamide indicates that KATP channel currents were recorded. (B) 80 nM PMA was
applied inside the membrane. (C) ATP was first applied inside the membrane at 10 µM and then 80 nM PMA was further
applied. Note that KATP activity was reduced by ATP, and application of PMA restored activity even in the presence of ATP.
Representative tracings at least from five experiments are shown. (D) I-V relationship of KATP in the absence of ATP without
(red circles) and with (black circles) 80 nM PMA. Data are from eight (without PMA) and six (with PMA) patches. (E) The val-
ues of open-time probability with and without 10 µM ATP inside the membrane are shown. Data with 80 nM PMA or with
PMA plus 1 µM BIM are also shown. Each value is the mean of at least five experiments. *P < 0.05, compared with data with 10
µM ATP in the absence of PMA. (F) Concentration-dependence for ATP inhibition of KATP activity with and without 80 nM
PMA. A series of experiments with ATP at various concentrations was carried out on the same patch. Data from twelve (with-
out PMA) and six (with 80 nM PMA) patches. Theoretical curves for data with (a black line) or without (a red line) PMA were
fitted to the Hill equation.BMC Pharmacology 2001, 1:3 http://www.biomedcentral.com/1471-2210/1/3
creased KATP activity (Fig. 3), it is obvious that the hyper-
polarization caused by PMA results from activation of
this channel type, and PMA inhibition of glucose-in-
duced electrical excitation of rat β -cells is ascribable at
least in part to hyperpolarization resulting from an in-
crease in KATP activity. The activity of KATP can be regu-
lated by changes in intracellular concentration of ATP
and/or ATP/ADP ratio [9]. In order to examine whether
PMA decrease β -cell ATP concentration, we measured
ATP content of rat islets, and results indicated that PMA
did not change ATP levels in islets (Table 1). It is not clear
at present whether ADP concentrations are changed by
the phorbol ester. Under a condition where ATP concen-
tration in the β -cell was clamped at a constant level, PMA
increased tolbutamide-sensitive currents in response to
voltage ramps from -90 to -50 mV (Fig. 4). Furthermore,
in inside-out single channel recordings, PMA restored
KATP activity, which had been reduced by the preceding
application of ATP (Figs. 6 panels C, E). Together, these
findings support the idea that PMA activation of KATP
does not result from a change in ATP concentration.
In cardiac myocytes, PMA is known to activate KATP
through activation of PKC [18–20]. In insulin-secreting
cell lines as well, PKC activation by PMA was shown to
potentiate KATP activity [11,12]. In the present study,
however, the activation of KATP activity by PMA is inde-
pendent on activation of PKC for two reasons. First, the
PKC activation inhibitor, BIM, did not prevent either the
PMA-induced hyperpolarization (Figs. 2 panels B & C) or
augmentation of whole-cell membrane currents (Fig. 4
panels C & D). Second, the non-PKC-stimulating phorbol
ester, 4α -PDD, mimicked the effect of PMA (Fig. 5 panel
C).
Pharmacological effects of PMA independent of activa-
tion of PKC have been demonstrated in various tissues
[23,24]. Since the magnitude of hyperpolarization in-
duced by PMA (Fig. 2 panel C) and the effects of PMA on
KATP activity (Fig. 6 panel E) were not significantly dif-
ferent between cells treated or untreated with BIM, acti-
vation of PKC seems to show little effect on KATP, at least
in this cell type. In this regard, the present findings sup-
port the idea derived from previous findings on mouse
[15] or obese-hyperglycaemic mouse β -cells [16]. Howev-
er, PMA-induced PKC-independent hyperpolarization of
β -cells was not previously reported [15,16]. The reason
for the discrepancy is not clear at the moment. The dif-
ference in species (rat in the present study and mouse in
previous studies) could be one explanation. In addition,
hyperpolarization in response to PMA might be unno-
ticed under some conditions with intracellular ATP at
particular concentrations, because, as shown in Fig. 6
panel F, the effect of PMA on KATP activity, which pro-
duces hyperpolarization, varied as a function of intracel-
lular ATP concentration.
There are two possible explanations for the PKC-inde-
pendent activation of KATP by phorbol esters: 1) phorbol
esters may increase KATP activity in an intracellular ATP-
independent manner and 2) phorbol esters may reduce
sensitivity of KATP to ATP. The first possibility can be dis-
counted because PMA does not affect KATP activity in the
absence of ATP (Fig. 6 panel B). On the other hand, PMA
restoration of KATP activity which had been reduced by
ATP (Fig. 6 panels C, E) supports the conclusion that
phorbol esters decrease KATP sensitivity to ATP.
Figure 7
Effect of PMA on insulin secretion in response to glucose
stimulation of rat isolated islets. The rates of insulin secre-
tion from rat islets were shown. Islets were separated into
two groups, treated and untreated with BIM. The rates of
insulin secretion were measured with glucose at 5.5 mM and
16.6 mM in the extracellular solution, respectively. 80 nM
PMA or 80 nM PM plus 1 µM BIM was compared with the
value obtained in islets without any treatment. Mean values
of 5–15 experiments are shown. Vertical bars indicate SE. *P
< 0.05. All measurements were performed at 37°C.
Table 1: ATP concentration of rat islets after loading with PMA 
or NaCN
Treatment ATP (pmole/islet) Pa)
none (with ethanolb)) 0.72 ± 0.07 (n = 13)
PMA (80 nM)c) 0.75 ± 0.10(n = 13) >0.05
none (without ethanol) 0.68 ± 0.08 (n = 8)
NaCN (I mM)d) 0.31 ± 0.04 (n = 8) <0.01
a)P value, compared with the value of the paired control (none). b)The 
concentration of ethanol was 0.01%. c)PMA was applied for 10 min. 
d)NaCN was applied for 10 min. All measurements were performed at 
37°C.BMC Pharmacology 2001, 1:3 http://www.biomedcentral.com/1471-2210/1/3
In the present study, application of PMA potentiated in-
sulin secretion from rat islets in response to elevation of
extracellular glucose concentration (Fig. 7), supporting
the hypothesis that activation of PKC synergizes secre-
tory process activated by the glucose stimulation [3–5].
BIM is known to selectively inhibit α  and β  PKC isotypes
[25], and rat pancreatic β -cells possess at least one PKC
isotype [2]. In fact, in this study, the treatment of islets
with BIM reversed the PMA effect on insulin secretion
(Fig. 7). Therefore, BIM can be used as a PKC inhibitor in
rat pancreatic β -cells, as already shown in other tissues
including murine macrophages [26], rat adrenal cortex
[27], human melanocytes [28] and rabbit vetricular my-
ocytes [20].
Recent reports with a truncated isoform of Kir6.2 have
revealed that an ATP-inhibitory site lies on the Kir6.2
subunit [29,30]. In addition, mutations of the C-termi-
nus of Kir6.2 showed that the amino acid sequence of the
C-terminus was responsible for regulation of ATP sensi-
tivity to KATP[31]. It is not clear at present whether phor-
bol ester effects reflection at the C-terminus. In addition,
other recent studies have shown that the membrane
phospholipid phosohatidylinositol-4,5-bis-phosphate
(PIP2) reduces sensitivity of KATP to ATP, and therefore,
activates KATP[32–34]. To our knowledge, this is the first
report of regulation of KATP activity by phorbol ester in
rat β -cells. The present findings provide new insight into
mechanisms of PMA regulation of insulin secretion by
PMA.
Conclusion
The major and important finding in this study is that
PMA impairs electrical excitation of rat pancreatic β -
cells through PKC-independent mechanism. PMA in-
creases KATP activity, induces a membrane hyperpolari-
zation, then reduces the electrical excitability of
pancreatic β -cells, leading to a decrease of insulin secre-
tion. Reduction of sensitivity of KATP to ATP seems to
underlie the PMA-induced impairment of β -cells electri-
cal excitation in response to glucose stimulation. These
results provide a novel insight of modulation mechanism
of insulin secretion by PMA, increases insulin secretion
by activation of PKC, and meanwhile decrease insulin se-
cretion by impairing β -cell excitability in a PKC-inde-
pendent manner in rat pancreatic β -cells.
Materials and Methods
Islet preparation and β -cell isolation
Isolation of rat islets was performed as previously de-
scribed [35,36]. In short, male adult rats (Wistar) were
anesthetized with diethyl ether, and 10 ml Hank's buff-
ered saline (HBSS) containing collagenase (200 U/ml,
Wako Chem., Japan) was injected into the common bile
duct. The pancreas swollen with digestion solution was
quickly excised and incubated in a plastic culture bottle
for 20 min at 37°C. The suspension obtained by shaking
the bottle was filtered through 0.5 mm metal mesh and
washed with HBSS including 2% bovine serum albumin
(BSA). About 100 islets were obtained from one rat with
the histopaque (specific gravity 1.077, Sigma, USA) gra-
dient method. After washing with HBSS containing 2%
BSA, islets were cultured for 24 hours with 5% C02 in the
tissue culture medium. Separation of islets was carried
out using dispase (1000 U/ml, Godo Shusei, Japan) as
previously described [35]. Separated cells were again
cultured for 1–4 days. Only single cells were chosen for
experiments. β -cells were identified by detecting the re-
sponses of the cells to 15 mM glucose or 0.5 mM tolbuta-
mide (Sigma, USA).
Patch-clamp recordings
Cells were kept in a 35-mm Petri dish, and the dish was
placed on the stage of an inverted microscope (IMT-2,
Olympus, Tokyo, Japan). Membrane potentials and
membrane currents were measured using a patch-clamp
amplifier (EPC-7, List Electronic, Darmstadt, Germany).
The nystatin-perforation method [37] was used to meas-
ure the membrane potential, and the standard method
was used to measure whole-cell currents [38]. The resist-
ance of the electrode, filled with the pipette solution,
ranged from 2 to 4 MΩ . To measure the whole-cell mem-
brane current, voltage ramp pulses from -90 to -50 mV
were repeatedly applied using a ramp pulse generator
(SET-2100, Nihon Kohden, Tokyo, Japan). The mem-
brane capacitance ranged from 8 to 14 pF. Series resist-
ances below 12 MΩ  were accepted. Single channel
current recordings were carried out by the cell-attached
and inside-out configurations. All electrophysiological
experiments were carried out at room temperature. Data
of single channel currents were low-pass filtered at 1
KHz, digitized at 10 KHz and analyzed using a single
channel current analysis program (QP-120J, Nihon Koh-
den). The open time probability (Po) of the single chan-
nel was calculated according to the equation Po = 1 - Pc1/
N where pc is the total closed time probability and N is
the total number of channels. The Po for KATP was shown
as function of the concentration of ATP. Theoretical
curves for ATP inhibition of KATP activity were fitted to
the Hill equation (P/Po)=l/{1+ ([ATP]/ki)h} where P is
the open time probability with ATP at each concentra-
tion, Po is the open time probability without ATP, [ATP]
is the concentration of ATP, ki is the ATP concentration
at which the inhibition is half maximal, and h is the Hill
coefficient.
Measurement of ATP content
The ATP concentration of islets was measured by the lu-
ciferin-luciferase method [39]. Assay kits (FL-ASC) were
purchased from Sigma. For ATP assay, 500 isolated ratBMC Pharmacology 2001, 1:3 http://www.biomedcentral.com/1471-2210/1/3
pancreatic islets were suspended in 1.2 ml standard ex-
tracellular solution. After application of PMA at the final
concentration of 80 nM, islet suspensions containing 17
islets were transferred to reaction tubes, and the amount
of emission was immediately measured using a lumines-
cence reader (BLR-301, Aloka, Japan). Bioluminescence
produced by the luciferin-luciferase reaction was ampli-
fied and output as the count rate (cpm) after converting
pulse signals. Using a calibration curve, values of count-
ing rate were calculated in terms of moles of ATP.
Measurement of insulin secretion
Isolated islets were hand-picked under microscopy, and
ten islets were distributed to each 35-mm Petri dish with
3 ml of HBSS containing 5.5 mM glucose, 20 mM
HEPES, and 2% BSA. After pre-incubation for 60 min,
islets were exposed to 1 µM BIM for 60 min, and then
measured insulin secretion rate. The PMA effects with or
without BIM on insulin secretion were measured by us-
ing immuno-reactive insulin (IRI) and stored at -20°C
until the assay. IRI was measured by RIA using anti-hu-
man insulin antibody with rat insulin standard (Radio-
immunoassay Kit, Insulin "Eiken", Tokyo Japan).
Solutions and Drugs
The standard extracellular solution contained 135 mM
NaCl, 5.6 mM KCl, 1.2 mM MgCl2, 1 mM CaCl2, 5 mM
glucose and 10 mM HEPES, pH 7.3. For membrane po-
tential recordings, the pipette solution contained 100
mM K-gluconate, 35 mM KCl, 5 mM glucose, 0.5 mM
EGTA, 10 mM HEPES and 200 mg/ml nystatin (Sigma,
St. Louis, MO, USA), pH 7.2. For whole-cell recordings,
the pipette solution contained 100 mM K-gluconate, 35
mM KCl, 1.2 mM MgCl2, 5 mM glucose, 0.5 mM EGTA,
10 mM HEPES, pH 7.2. For cell-attached and inside-out
single channel recordings, the pipette solution contained
135 mM KCl, 1.2 mM MgCl2, 5 mM glucose, 0.5 mM
EGTA and 10 mM HEPES, pH 7.3. The ionic composition
of the solution inside the membrane (bath solution) in
inside-out recordings was the same as that of the pipette
solution, but the pH of this solution was 7.2. In inside-
out recordings, ATP was added to the bath solution at
various concentrations. Phorbol 12-myristate 13-acetate
(PMA), 4a-phorbol 12,13-didecanoate (4a-PDD), bisin-
dolylmaleimide (BIM) and NaCN were purchased from
Sigma. PMA and 4a-PDD were dissolved in ethanol, and
the final concentration of ethanol in the experimental so-
lution was less than 0.01%. BIM was dissolved in DMSO,
and the final concentration of DMSO in the experimental
solution was 0.1%. Cells in the experimental bath were
continuously exposed to a stream of the extracellular so-
lution throughout the experiment. In the use of BIM, is-
lets or cells were preincubated in the solution containing
BIM (50 µM) for 30–60 min, and BIM was present in the
bath solution throughout the experiment
Statistics
Data were expressed as mean ± SE of several experi-
ments, and statistical significance was evaluated by the
two-tail paired and unpaired Student's t-tests. A value of
P less than 0.05 was accepted as significant.
This study was carried out in accordance with the Guide-
lines for Animal Experimentation, Hirosaki University,
Japan.
List of abbreviations
phorbol 12-myristate 13-acetate (PMA), protein kinase C
(PKC), ATP-sensitive K+ channel (KATP), 4a-phorbol
12,13-didecanoate (4a-PDD), bisindolylmaleimide
(BIM).
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